Speaker illustration

Doctor Olga Petyunina

L.T.Malaya Institute of Therapy, Kharkiv (Ukraine)

I am the senior researcher of department of prevention and treatment of emergency conditions of Government institution “L.T. Malaya Therapy National Institute of the National Academy of medical science of Ukraine”, Kharkiv, Ukraine. My scientific interest includes origins of appearance, cource and treatment of patients with myocardial infarction, heart failure.After Medical University, at 1995, I was recommended to scientific work and graduated magistracy and then aspirantura with defence PhD in 2000. At 2001 I received specialization “cardiologist” . Since 2003г. till now I am an active participant of clinical trials as a co-investigator, among them - ARIES, ENGAGE, ATLAS, IMPROVE-IT, AMG-145, ROCKET, RIVA, ENTRUST, AEGIS-II etc. In 2016 I planned doctoral dissertation by the topic: Pecularities of prognostication of clinical outcomes after ST-segment elevation myocardial infarction on the basis of left ventricular remodeling, neurohumoral and proinflammation activity evaluation.

The role of single nucleotide polymorphism of val66met (rs6265) of the brain-derived neurotropic factor in formation of endpoints after st-segment elevation myocardial infarction

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Biomarkers

Session: Acute Coronary Syndromes ePosters

Thumbnail

The predictive role of t786c single nucleotide polymorphism in endothelial no-synthase gene in late left ventricular remodeling after st-segment elevation myocardial infarction

Event: ESC CONGRESS 2019

Topic: Left Ventricular Remodelling

Session: Acute Coronary Syndromes

Thumbnail

Elevated levels of circulating soluble st2 at discharge predicts late ventricular adverse remodeling in patients with st-segment elevation myocardial infarction

Event: EuroPrevent 2019

Topic: Coronary Artery Disease, Other

Session: Coronary Artery Disease

Thumbnail

The utility of serum soluble st2 measured at discharge in prognostication of late ventricular adverse remodeling in patients with st-segment elevation myocardial infarction

Event: Acute Cardiovascular Care 2019

Topic: Biomarkers

Session: Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention

Thumbnail

This platform is supported by

logo Novo Nordisk